AtriCure Inc (ATRC) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

AtriCure, Inc.

Total Revenue Chart for AtriCure Inc

AtriCure Inc (ATRC) revenue for FY2025 was USD 534.5M, a 14.9% change from FY2024. AtriCure Inc's revenue grew from USD 20.0K in 2001 to USD 534.5M in 2025 (2672540.0% over 24 years). Earnings per share moved from USD -0.35 in 2011 to USD -1.02 in 2022. Revenue compound annual growth rate: 5-year CAGR of 20.9%, 10-year CAGR of 15.2%, 20-year CAGR of 15.3%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (US Dollars)

R&D as % of Revenue

Key Stats

Market Cap
$2.85B
Implied Share Price
$56.07
Enterprise Value
$2.95B
Revenue (TTM)
$569.62M
EBITDA
$33.75M
Profit Margin
1.85%
Trailing P/E
267.00
Forward P/E
232.56
Price/Book (MRQ)
5.79
Price/Sales (TTM)
5.01
EV/EBITDA
75.06
EV/Revenue
5.08
Dividend Yield
—
Book Value
$10.15
Free Cash Flow (FY2025)
$48.28M
Free Cash Flow Yield
1.69%

Snapshot as of 18th October 2026 — not point-in-time controlled, may lag the live market by a few days.